Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach
- PMID: 38245876
- DOI: 10.1007/s00705-023-05955-8
Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach
Abstract
MicroRNAs (miRNAs) have been the subject of extensive research for many years, primarily in the context of diseases such as cancer. However, our appreciation of their significance in viral infections, particularly in hepatitis, has increased due to the discovery of their association with both the host and the virus. Hepatitis is a major global health concern and can be caused by various viruses, including hepatitis A to E. This review highlights the key factors associated with miRNAs and their involvement in infections with various viruses that cause hepatitis. The review not only emphasizes the expression profiles of miRNAs in hepatitis but also puts a spotlight on their potential for diagnostics and therapeutic interventions. Ongoing extensive studies are propelling the therapeutic application of miRNAs, addressing both current limitations and potential strategies for the future of miRNAs in personalized medicine. Here, we discuss the potential of miRNAs to influence future medical research and an attempt to provide a thorough understanding of their diverse roles in hepatitis and beyond.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Similar articles
-
Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.World J Gastroenterol. 2015 Jun 28;21(24):7375-99. doi: 10.3748/wjg.v21.i24.7375. World J Gastroenterol. 2015. PMID: 26139985 Free PMC article. Review.
-
Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals.Int J Mol Sci. 2022 Sep 11;23(18):10536. doi: 10.3390/ijms231810536. Int J Mol Sci. 2022. PMID: 36142450 Free PMC article. Review.
-
Complex interactions between microRNAs and hepatitis B/C viruses.World J Gastroenterol. 2014 Oct 7;20(37):13477-92. doi: 10.3748/wjg.v20.i37.13477. World J Gastroenterol. 2014. PMID: 25309078 Free PMC article. Review.
-
Novel microRNA-like viral small regulatory RNAs arising during human hepatitis A virus infection.FASEB J. 2014 Oct;28(10):4381-93. doi: 10.1096/fj.14-253534. Epub 2014 Jul 1. FASEB J. 2014. PMID: 25002121
-
Comprehensive profiling and characterization of cellular miRNAs in response to hepatitis A virus infection in human fibroblasts.Infect Genet Evol. 2016 Nov;45:176-186. doi: 10.1016/j.meegid.2016.08.035. Epub 2016 Aug 31. Infect Genet Evol. 2016. PMID: 27590712
Cited by
-
Potential Benefits of In Silico Methods: A Promising Alternative in Natural Compound's Drug Discovery and Repurposing for HBV Therapy.Pharmaceuticals (Basel). 2025 Mar 16;18(3):419. doi: 10.3390/ph18030419. Pharmaceuticals (Basel). 2025. PMID: 40143195 Free PMC article. Review.
References
-
- O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402. https://doi.org/10.3389/FENDO.2018.00402 - DOI - PubMed
-
- Chandan K, Gupta M, Sarwat M (2019) Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases. Front Immunol 10:3081. https://doi.org/10.3389/FIMMU.2019.03081 - DOI - PubMed
-
- Wang X, He Y, MacKowiak B, Gao B (2021) MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut 70:784–795. https://doi.org/10.1136/gutjnl-2020-322526 - DOI - PubMed
-
- Shrivastava S, Steele R, Ray R, Ray RB (2015) MicroRNAs: Role in hepatitis C virus pathogenesis. Genes Dis 2:35–45. https://doi.org/10.1016/J.GENDIS.2015.01.001 - DOI - PubMed - PMC
-
- Trobaugh DW, Klimstra WB (2017) MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med 23:80–93. https://doi.org/10.1016/J.MOLMED.2016.11.003 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical